Balance Sheet
Cash Flow Statement
Change in Account PayablesChange in Inventory
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mainz Biomed (MYNZ) Share-based Compensation (2022 - 2023)

Historic Share-based Compensation for Mainz Biomed (MYNZ) over the last 2 years, with Q4 2023 value amounting to $818991.0.

  • Mainz Biomed's Share-based Compensation fell 4739.17% to $818991.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $4.0 million, marking a year-over-year decrease of 5922.67%. This contributed to the annual value of $1.1 million for FY2024, which is 7162.92% down from last year.
  • Latest data reveals that Mainz Biomed reported Share-based Compensation of $818991.0 as of Q4 2023, which was down 4739.17% from $1.1 million recorded in Q3 2023.
  • Over the past 5 years, Mainz Biomed's Share-based Compensation peaked at $2.9 million during Q1 2022, and registered a low of $818991.0 during Q4 2023.